Pharming Group's revenue grew 26% in Q2

seekingalpha.com

Pharming Group reported a strong Q2 2025 with 26% revenue growth and a $12.9 million operating profit. This growth was driven by RUCONEST's 28% year-on-year increase and accelerated patient uptake of Joenja. The company upgraded its full-year 2025 revenue guidance due to this positive momentum.


With a significance score of 1.6, this news ranks in the top 28% of today's 23154 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Pharming Group's revenue grew 26% in Q2 | News Minimalist